Evidence map›Paper›PMID 40312568›Full record

ArticleNature aging2025

Aging promotes reactivation of the Barr body at distal chromosome regions.

Sarah Hoelzl, Tim P Hasenbein, Stefan Engelhardt, Daniel Andergassen

Abstract read
In one paragraph

Article in Nature aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Age-related erosion of X chromosome inactivation in human tissues.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. ECHOS enables spatial epigenome profiling at subcellular resolution.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarah HoelzlInstitute of Pharmacology and Toxicology, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-0308-8522
Tim P HasenbeinInstitute of Pharmacology and Toxicology, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-7028-6559
Stefan EngelhardtInstitute of Pharmacology and Toxicology, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-5378-8661
Daniel AndergassenInstitute of Pharmacology and Toxicology, Technical University Munich, Munich, Germany. daniel.andergassen@tum.de.ORCID http://orcid.org/0000-0003-1196-4289

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Decades ago, evidence of age-related reactivation of a single gene on the female inactive X chromosome was observed in mice. While stable silencing of the Barr body is crucial for balancing gene dosage between sexes, it remains unclear whether silencing is maintained during aging. Here we used allele-specific multi-omics approaches to capture a comprehensive catalog of genes escaping X chromosome inactivation throughout mouse development and aging. We found substantially elevated escape rates during aging across organs, occurring in multiple distinct cell types and concentrated at distal chromosome regions. Consistently, chromatin accessibility was increased across multiple megabases at chromosome ends, affecting regulatory elements of escapees. As several age-specific escapees are linked to human diseases, their elevated expression in females might contribute to sex-biased disease progression observed during aging.

Indexed as

AgingX Chromosome InactivationAnimalsChromatinFemaleMaleMiceMice, Inbred C57BLChromatin

Identifiers

PMID40312568
PMCPMC12176624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.